Combined treatment with ursodeoxycholic acid and pioglitazone in a patient with NASH associated with type 2 diabetes and psoriasis.
Itoh
Susumu
S
Division of Hepatology, Kasori Hospital, Chiba, Japan. s.itoh@kasori.seikei-kai.or.jp
Kanazuka
Azuma
A
Akimoto
Takahide
T
D000368:Aged; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005234:Fatty Liver / Q000150:complications / Q000188:drug therapy*; D006505:Hepatitis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D000077205:Pioglitazone; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D045162:Thiazolidinediones / Q000627:therapeutic use*; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
D002756:Cholagogues and Choleretics; D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D014580:Ursodeoxycholic Acid; D000077205:Pioglitazone